Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Genetically engineered herpes virus for the treatment of cardiovascular disease

Genetically engineered herpes virus for the treatment of cardiovascular disease

US Patent 6846670 · Granted Jan 25, 2005

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Absorbable intravascular devices that shorten upon expansion creating space for 2025
Absorbable intravascular devices that exhibit their greatest radial strength at 2025
Absorbable intravascular devices that provide a decrease in radial rigidity of t2024
System and method for multi-site radiotherapy2024
Radially rigid and longitudinally flexible multi-element intravascular stent2023
Absorbable intravascular devices that shorten upon expansion creating space for 2022
Multi-element bioresorbable intravascular stent2022
PUM 1 protein as target for virus inhibition2021
Absorbable intravascular devices that provide a decrease in radial rigidity of t2020
Multi-element bioresorbable intravascular stent2020
Anti-tumor therapy2020
Anti-tumor therapy2020